Vinorelbine (NVB)-carboplatin (CBDCA) vs non-platinum doublets in inoperable non-small cell lung cancer (NSCLC) patients (pts)-final results of the Glob 2 phase III with patient benefit analysis

• Abratt, R. P. Groote Schuur Hospital, Cape Town, South Africa; Mazowieckie Centrum Leczenia, Otwock, Poland; Helsinki University Central Hospital, Helsinki, Finland; Onkologie/Hämatologie Kantonsspital, Aarau, Switzerland; Masaryk Hospital, Usti nad Labem, Czech Republic; Westmead Hospital, Sydney, Australia; Hospital San Juan de Alicante, San Juan de Alicante, Spain; AOS Giovanni Battista Molinette, Torino, Italy; Krankenhaus Grosshandorf, Grosshandorf, Germany; National Cancer Centre, Singapore, Singapore
• Szczesna, A. Groote Schuur Hospital, Cape Town, South Africa; Mazowieckie Centrum Leczenia, Otwock, Poland; Helsinki University Central Hospital, Helsinki, Finland; Onkologie/Hämatologie Kantonsspital, Aarau, Switzerland; Masaryk Hospital, Usti nad Labem, Czech Republic; Westmead Hospital, Sydney, Australia; Hospital San Juan de Alicante, San Juan de Alicante, Spain; AOS Giovanni Battista Molinette, Torino, Italy; Krankenhaus Grosshandorf, Grosshandorf, Germany; National Cancer Centre, Singapore, Singapore
• Mattson, K. Groote Schuur Hospital, Cape Town, South Africa; Mazowieckie Centrum Leczenia, Otwock, Poland; Helsinki University Central Hospital, Helsinki, Finland; Onkologie/Hämatologie Kantonsspital, Aarau, Switzerland; Masaryk Hospital, Usti nad Labem, Czech Republic; Westmead Hospital, Sydney, Australia; Hospital San Juan de Alicante, San Juan de Alicante, Spain; AOS Giovanni Battista Molinette, Torino, Italy; Krankenhaus Grosshandorf, Grosshandorf, Germany; National Cancer Centre, Singapore, Singapore
• Wernli, M. Groote Schuur Hospital, Cape Town, South Africa; Mazowieckie Centrum Leczenia, Otwock, Poland; Helsinki University Central Hospital, Helsinki, Finland; Onkologie/Hämatologie Kantonsspital, Aarau, Switzerland; Masaryk Hospital, Usti nad Labem, Czech Republic; Westmead Hospital, Sydney, Australia; Hospital San Juan de Alicante, San Juan de Alicante, Spain; AOS Giovanni Battista Molinette, Torino, Italy; Krankenhaus Grosshandorf, Grosshandorf, Germany; National Cancer Centre, Singapore, Singapore
• Reiterer, P. Groote Schuur Hospital, Cape Town, South Africa; Mazowieckie Centrum Leczenia, Otwock, Poland; Helsinki University Central Hospital, Helsinki, Finland; Onkologie/Hämatologie Kantonsspital, Aarau, Switzerland; Masaryk Hospital, Usti nad Labem, Czech Republic; Westmead Hospital, Sydney, Australia; Hospital San Juan de Alicante, San Juan de Alicante, Spain; AOS Giovanni Battista Molinette, Torino, Italy; Krankenhaus Grosshandorf, Grosshandorf, Germany; National Cancer Centre, Singapore, Singapore
• Hui, R. Groote Schuur Hospital, Cape Town, South Africa; Mazowieckie Centrum Leczenia, Otwock, Poland; Helsinki University Central Hospital, Helsinki, Finland; Onkologie/Hämatologie Kantonsspital, Aarau, Switzerland; Masaryk Hospital, Usti nad Labem, Czech Republic; Westmead Hospital, Sydney, Australia; Hospital San Juan de Alicante, San Juan de Alicante, Spain; AOS Giovanni Battista Molinette, Torino, Italy; Krankenhaus Grosshandorf, Grosshandorf, Germany; National Cancer Centre, Singapore, Singapore
• Lizon, J. Groote Schuur Hospital, Cape Town, South Africa; Mazowieckie Centrum Leczenia, Otwock, Poland; Helsinki University Central Hospital, Helsinki, Finland; Onkologie/Hämatologie Kantonsspital, Aarau, Switzerland; Masaryk Hospital, Usti nad Labem, Czech Republic; Westmead Hospital, Sydney, Australia; Hospital San Juan de Alicante, San Juan de Alicante, Spain; AOS Giovanni Battista Molinette, Torino, Italy; Krankenhaus Grosshandorf, Grosshandorf, Germany; National Cancer Centre, Singapore, Singapore
• Bertetto, O. Groote Schuur Hospital, Cape Town, South Africa; Mazowieckie Centrum Leczenia, Otwock, Poland; Helsinki University Central Hospital, Helsinki, Finland; Onkologie/Hämatologie Kantonsspital, Aarau, Switzerland; Masaryk Hospital, Usti nad Labem, Czech Republic; Westmead Hospital, Sydney, Australia; Hospital San Juan de Alicante, San Juan de Alicante, Spain; AOS Giovanni Battista Molinette, Torino, Italy; Krankenhaus Grosshandorf, Grosshandorf, Germany; National Cancer Centre, Singapore, Singapore
• Reck, M. Groote Schuur Hospital, Cape Town, South Africa; Mazowieckie Centrum Leczenia, Otwock, Poland; Helsinki University Central Hospital, Helsinki, Finland; Onkologie/Hämatologie Kantonsspital, Aarau, Switzerland; Masaryk Hospital, Usti nad Labem, Czech Republic; Westmead Hospital, Sydney, Australia; Hospital San Juan de Alicante, San Juan de Alicante, Spain; AOS Giovanni Battista Molinette, Torino, Italy; Krankenhaus Grosshandorf, Grosshandorf, Germany; National Cancer Centre, Singapore, Singapore
• Tan, E. H. Groote Schuur Hospital, Cape Town, South Africa; Mazowieckie Centrum Leczenia, Otwock, Poland; Helsinki University Central Hospital, Helsinki, Finland; Onkologie/Hämatologie Kantonsspital, Aarau, Switzerland; Masaryk Hospital, Usti nad Labem, Czech Republic; Westmead Hospital, Sydney, Australia; Hospital San Juan de Alicante, San Juan de Alicante, Spain; AOS Giovanni Battista Molinette, Torino, Italy; Krankenhaus Grosshandorf, Grosshandorf, Germany; National Cancer Centre, Singapore, Singapore

Cancer Research

Oncology